Immediate Impact
3 from Science/Nature 53 standout
Citing Papers
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2023 Standout
Coeliac disease
2022 Standout
Works of Collin Barker being referenced
Can Tissue Transglutaminase Antibody Titers Replace Small-Bowel Biopsy to Diagnose Celiac Disease in Select Pediatric Populations?
2005
Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial.
1993
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Collin Barker | 471 | 249 | 271 | 32 | 1.0k | |
| D. O’B. Hourihane | 323 | 161 | 452 | 38 | 1.4k | |
| Robert Bagin | 235 | 288 | 176 | 25 | 1.1k | |
| Martin Gregory | 255 | 343 | 141 | 34 | 1.2k | |
| H Gordon | 301 | 74 | 279 | 33 | 959 | |
| Joel B. Levine | 245 | 214 | 169 | 31 | 1.0k | |
| Michael J. Burt | 410 | 500 | 126 | 27 | 1.3k | |
| Battista Fabio Viola | 223 | 81 | 390 | 25 | 1.4k | |
| Hermenegildo de la Calle | 447 | 143 | 97 | 37 | 1.3k | |
| Petros Zezos | 430 | 320 | 141 | 62 | 955 | |
| Onye E. Akwari | 673 | 109 | 343 | 29 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...